Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Petros Grivas, MD, PhD, summarizes the clinical progress made in prostate cancer from ESMO 2020

Dr. Grivas, Physician, Seattle Cancer Care Alliance, Associate Professor, Division of Medical Oncology, University of Washington School of Medicine, Clinical Director, Genitourinary Cancers Program, UW Medicine, Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center, summarizes the clinical progress made at the 2020 ESMO Virtual Congress in prostate cancer as seen in three major studies

Tags: ESMOProstate

Published: 25 September 2020

Recent Videos

video

Eleni Efstathiou, MD, PhD, shares thoughts on the TROPHY-U-01 clinical study presented at ESMO 2020

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, provides perspective on the IPATential150 study in mCRPC

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, on whether genetic mutation data impacts the treatment of prostate cancer

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, on the practice-changing potential of the PROfound study from ESMO 2020

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, regarding patients more likely to respond to nivolumab + cabozantinib

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, offers opinion on whether CheckMate 9ER is practice-changing

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, discusses the CheckMate 9ER clinical trial presented at ESMO 2020

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Matthew Galsky, MD, on how studies focused on genetic mutations impact prostate cancer treatment

Dr. Galsky, Professor of Medicine, Director of Genitourinary Medical Oncology, Director of the Novel Therapeutics Unit, and Co-Director, Center of ...

video

Arun Azad, MBBS, PhD, FRACP, on the evolving treatment landscape of advanced prostate cancer

Dr. Azad, Associate Professor, Medical Oncologist, Peter MacCallum Cancer Centre, Victoria, Australia, speculates on how recent clinical trials focused on ...

video

Matthew Galsky, MD, discusses the practice-changing potential of the PROfound study from ESMO 2020

Dr. Galsky, Professor of Medicine, Director of Genitourinary Medical Oncology, Director of the Novel Therapeutics Unit, and Co-Director, Center of ...

Related Videos

video-image

Eleni Efstathiou, MD, PhD, shares thoughts on the TROPHY-U-01 clinical study presented at ESMO 2020

video-image

Eleni Efstathiou, MD, PhD, discusses the CheckMate 9ER clinical trial presented at ESMO 2020

video-image

Eleni Efstathiou, MD, PhD, offers opinion on whether CheckMate 9ER is practice-changing

video-image

Eleni Efstathiou, MD, PhD, regarding patients more likely to respond to nivolumab + cabozantinib

video-image

Eleni Efstathiou, MD, PhD, on the practice-changing potential of the PROfound study from ESMO 2020

video-image

Eleni Efstathiou, MD, PhD, on whether genetic mutation data impacts the treatment of prostate cancer

video-image

Eleni Efstathiou, MD, PhD, provides perspective on the IPATential150 study in mCRPC

video-image

Ken Kato, MD, PhD, on the role of PD-L1 biomarkers in the treatment of esophageal cancer

video-image

Matthew Galsky, MD, discusses the practice-changing potential of the PROfound study from ESMO 2020

video-image

Arun Azad, MBBS, PhD, FRACP, on the evolving treatment landscape of advanced prostate cancer

video-image

Ken Kato, MD, PhD, shares the design and outcomes of the Keynote-590 trial from ESMO 2020

video-image

Matthew Galsky, MD, on how studies focused on genetic mutations impact prostate cancer treatment

video-image

Matthew Galsky, MD, regarding the TROPHY-U-01 study presented at the 2020 ESMO Virtual Congress

video-image

Arun Azad, MBBS, PhD, FRACP, shares impressions of the post-hoc analysis of the ARCHES study

video-image

Ken Kato, MD, PhD, regarding the treatment of adenocarcinoma versus squamous cell carcinoma

video-image

Matthew Galsky, MD, on the CheckMate-274 study in high risk, muscle-invasive urothelial carcinoma

video-image

Arun Azad, MBBS, PhD, FRACP, tells us about the outcomes of the PROfound study presented at ESMO '20

video-image

Matthew Galsky, MD, considers the implications of the IMvigor130 clinical study

video-image

Arun Azad, MBBS, PhD, FRACP, considers how recent clinical trials influence the treatment of mCRPC

video-image

Elizabeth Mittendorf, MD, PhD, considers key takeaways from the Impassion-131 presented at ESMO 2020